Troriluzole Fails First Phase III Test As Biohaven Looks Beyond Migraine

Closed up finger on keyboard with word CLINICAL TRIALS
Troriluzole failed in anxiety, but has three other readouts in 2020 and 2021.

More from Clinical Trials

More from R&D